Genomics in Egypt: Current Status and Future Aspects

Egypt is the third most densely inhabited African country. Due to the economic burden and healthcare costs of overpopulation, genomic and genetic testing is a huge challenge. However, in the era of precision medicine, Egypt is taking a shift in approach from “one-size-fits all” to more personalized...

Full description

Bibliographic Details
Main Authors: Eman Ahmed El-Attar, Rasha Mohamed Helmy Elkaffas, Sarah Ahmed Aglan, Iman S. Naga, Amira Nabil, Hoda Y. Abdallah
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.797465/full
_version_ 1818009039930392576
author Eman Ahmed El-Attar
Rasha Mohamed Helmy Elkaffas
Sarah Ahmed Aglan
Iman S. Naga
Amira Nabil
Hoda Y. Abdallah
Hoda Y. Abdallah
author_facet Eman Ahmed El-Attar
Rasha Mohamed Helmy Elkaffas
Sarah Ahmed Aglan
Iman S. Naga
Amira Nabil
Hoda Y. Abdallah
Hoda Y. Abdallah
author_sort Eman Ahmed El-Attar
collection DOAJ
description Egypt is the third most densely inhabited African country. Due to the economic burden and healthcare costs of overpopulation, genomic and genetic testing is a huge challenge. However, in the era of precision medicine, Egypt is taking a shift in approach from “one-size-fits all” to more personalized healthcare via advancing the practice of medical genetics and genomics across the country. This shift necessitates concrete knowledge of the Egyptian genome and related diseases to direct effective preventive, diagnostic and counseling services of prevalent genetic diseases in Egypt. Understanding disease molecular mechanisms will enhance the capacity for personalized interventions. From this perspective, we highlight research efforts and available services for rare genetic diseases, communicable diseases including the coronavirus 2019 disease (COVID19), and cancer. The current state of genetic services in Egypt including availability and access to genetic services is described. Drivers for applying genomics in Egypt are illustrated with a SWOT analysis of the current genetic/genomic services. Barriers to genetic service development in Egypt, whether economic, geographic, cultural or educational are discussed as well. The sensitive topic of communicating genomic results and its ethical considerations is also tackled. To understand disease pathogenesis, much can be gained through the advancement and integration of genomic technologies via clinical applications and research efforts in Egypt. Three main pillars of multidisciplinary collaboration for advancing genomics in Egypt are envisaged: resources, infrastructure and training. Finally, we highlight the recent national plan to establish a genome center that will aim to prepare a map of the Egyptian human genome to discover and accurately determine the genetic characteristics of various diseases. The Reference Genome Project for Egyptians and Ancient Egyptians will initialize a new genomics era in Egypt. We propose a multidisciplinary governance system in Egypt to support genomic medicine research efforts and integrate into the healthcare system whilst ensuring ethical conduct of data.
first_indexed 2024-04-14T05:37:00Z
format Article
id doaj.art-d9cd243928f5469bbaa53abc86bf221e
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-04-14T05:37:00Z
publishDate 2022-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-d9cd243928f5469bbaa53abc86bf221e2022-12-22T02:09:36ZengFrontiers Media S.A.Frontiers in Genetics1664-80212022-05-011310.3389/fgene.2022.797465797465Genomics in Egypt: Current Status and Future AspectsEman Ahmed El-Attar0Rasha Mohamed Helmy Elkaffas1Sarah Ahmed Aglan2Iman S. Naga3Amira Nabil4Hoda Y. Abdallah5Hoda Y. Abdallah6Chemical Pathology Department, Medical Research Institute, Alexandria University, Alexandria, EgyptClinical and Chemical Pathology Department, Faculty of Medicine, Cairo University, Cairo, EgyptChemical Pathology Department, Medical Research Institute, Alexandria University, Alexandria, EgyptDepartment of Microbiology, Medical Research Institute, Alexandria University, Alexandria, EgyptDepartment of Human Genetics, Medical Research Institute, Alexandria University, Alexandria, EgyptMedical Genetics Unit, Histology and Cell Biology Department, Faculty of Medicine, Suez Canal University, Ismailia, EgyptCenter of Excellence in Molecular and Cellular Medicine, Faculty of Medicine, Suez Canal University, Ismailia, EgyptEgypt is the third most densely inhabited African country. Due to the economic burden and healthcare costs of overpopulation, genomic and genetic testing is a huge challenge. However, in the era of precision medicine, Egypt is taking a shift in approach from “one-size-fits all” to more personalized healthcare via advancing the practice of medical genetics and genomics across the country. This shift necessitates concrete knowledge of the Egyptian genome and related diseases to direct effective preventive, diagnostic and counseling services of prevalent genetic diseases in Egypt. Understanding disease molecular mechanisms will enhance the capacity for personalized interventions. From this perspective, we highlight research efforts and available services for rare genetic diseases, communicable diseases including the coronavirus 2019 disease (COVID19), and cancer. The current state of genetic services in Egypt including availability and access to genetic services is described. Drivers for applying genomics in Egypt are illustrated with a SWOT analysis of the current genetic/genomic services. Barriers to genetic service development in Egypt, whether economic, geographic, cultural or educational are discussed as well. The sensitive topic of communicating genomic results and its ethical considerations is also tackled. To understand disease pathogenesis, much can be gained through the advancement and integration of genomic technologies via clinical applications and research efforts in Egypt. Three main pillars of multidisciplinary collaboration for advancing genomics in Egypt are envisaged: resources, infrastructure and training. Finally, we highlight the recent national plan to establish a genome center that will aim to prepare a map of the Egyptian human genome to discover and accurately determine the genetic characteristics of various diseases. The Reference Genome Project for Egyptians and Ancient Egyptians will initialize a new genomics era in Egypt. We propose a multidisciplinary governance system in Egypt to support genomic medicine research efforts and integrate into the healthcare system whilst ensuring ethical conduct of data.https://www.frontiersin.org/articles/10.3389/fgene.2022.797465/fullgenomicsEgyptcancercommunicable diseaseCOVID 19governance
spellingShingle Eman Ahmed El-Attar
Rasha Mohamed Helmy Elkaffas
Sarah Ahmed Aglan
Iman S. Naga
Amira Nabil
Hoda Y. Abdallah
Hoda Y. Abdallah
Genomics in Egypt: Current Status and Future Aspects
Frontiers in Genetics
genomics
Egypt
cancer
communicable disease
COVID 19
governance
title Genomics in Egypt: Current Status and Future Aspects
title_full Genomics in Egypt: Current Status and Future Aspects
title_fullStr Genomics in Egypt: Current Status and Future Aspects
title_full_unstemmed Genomics in Egypt: Current Status and Future Aspects
title_short Genomics in Egypt: Current Status and Future Aspects
title_sort genomics in egypt current status and future aspects
topic genomics
Egypt
cancer
communicable disease
COVID 19
governance
url https://www.frontiersin.org/articles/10.3389/fgene.2022.797465/full
work_keys_str_mv AT emanahmedelattar genomicsinegyptcurrentstatusandfutureaspects
AT rashamohamedhelmyelkaffas genomicsinegyptcurrentstatusandfutureaspects
AT sarahahmedaglan genomicsinegyptcurrentstatusandfutureaspects
AT imansnaga genomicsinegyptcurrentstatusandfutureaspects
AT amiranabil genomicsinegyptcurrentstatusandfutureaspects
AT hodayabdallah genomicsinegyptcurrentstatusandfutureaspects
AT hodayabdallah genomicsinegyptcurrentstatusandfutureaspects